Antonello (Tony) Punturieri, M.D., Ph.D.: November 15, 2018

CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IS A LEADING CAUSE OF DEATH IN U.S. 

LUNG DISEASE SIGNIFICANTLY HIGHER IN RURAL AREAS

Antonello (Tony) Punturieri, M.D., Ph.D.

Program Director, Division of Lung Diseases at the National Heart, Lung, and Blood Institute (NHLBI) at the National Institutes of Health (NIH).

 

One of the leading causes of death in the United States, chronic obstructive pulmonary disease, or COPD, affects millions of Americans. Beyond the 16 million who are diagnosed with the disease, millions more suffer with COPD-like symptoms and are likely unaware that they have it. While COPD affects people across the country, the burden is even higher in rural areas, where prevalence is almost double that of urban areas. The disease, which is expected to cost $49 billion a year on COPD-related care by 2020, can stifle a person’s ability to breathe, lead to long-term disability, and dramatically affect quality of life.

Many mistake COPD’s steadily-worsening symptoms – shortness of breath, chronic coughing, and wheezing – for problems that naturally come with aging or being out of shape. As a result, many patients delay seeking a diagnosis. Over time, the lung disease can greatly impact one’s quality of life and ability to complete everyday tasks. However, COPD is highly treatable and early diagnosis can ease signs and symptoms and improve outcomes.

On November 15th, Dr. Antonello Punturieri, Program Director in the Division of Lung Diseases, will be available to discuss COPD – what it is, who’s at risk and how diagnosis and treatment can improve one’s quality of life.

 

For more information on COPD and resources

visit NHLBI’s COPD Learn More Breather Better® website,

 www.COPD.nhlbi.nih.gov

More About Dr. Antonello (Tony) Punturieri:

Antonello (Tony) Punturieri, MD, Ph.D., is a Program Officer in the Division of Lung Diseases (DLD), NHLBI, NIH. In this capacity, Dr. Punturieri administers a varied portfolio of grants and contracts in the area of COPD and environment. Specifically, Dr. Punturieri participates in the development and administration of programs that aim at the understanding of COPD disease mechanisms, COPD prevention, and the testing and evaluation of COPD therapies.

Dr. Punturieri attended Medical School in Ferrara (Italy) and obtained a Ph.D. in Immunology at La Sapienza University in Rome, Italy. He spent four years at NIH as Visiting Fellow at NIDDK and Visiting Associate at NIAID. He returned to Rome as Assistant Professor of Pathophysiology at La Sapienza University in Rome (Italy) while also working as Staff Scientist at Regina Elena Cancer Institute. He then moved to the Division of Hematology/Oncology at the University of Michigan, Ann Arbor, MI, and subsequently joined the Pulmonary Division at Michigan and the Veterans Administration Hospital (Pulmonary Section) in Ann Arbor. He joined NHLBI in 2006.

Speak Your Mind

*